Your browser doesn't support javascript.
loading
Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies.
Allan, John N; Pinilla-Ibarz, Javier; Gladstone, Douglas E; Patel, Krish; Sharman, Jeff P; Wierda, William G; Choi, Michael Y; O'Brien, Susan M; Shadman, Mazyar; Davids, Matthew S; Pagel, John M; Yimer, Habte A; Ward, Renee; Acton, Gary; Taverna, Pietro; Combs, Daniel L; Fox, Judith A; Furman, Richard R; Brown, Jennifer R.
Afiliación
  • Allan JN; Weill Cornell Medicine, Department of Medicine, New York.
  • Pinilla-Ibarz J; Moffitt Cancer Center, Tampa, FL.
  • Gladstone DE; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Patel K; Swedish Cancer Institute, Seattle, WA.
  • Sharman JP; Willamette Valley Cancer Institute/US Oncology, Eugene, OR.
  • Wierda WG; MD Anderson Cancer Center, Houston, TX.
  • Choi MY; Moores Cancer Center, University of California San Diego, La Jolla, CA.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA.
  • Shadman M; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Davids MS; CLL Center, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Pagel JM; Swedish Cancer Institute, Seattle, WA.
  • Yimer HA; Texas Oncology/US Oncology Research, Tyler, TX.
  • Ward R; Sunesis Pharmaceuticals, South San Francisco, CA.
  • Acton G; Sunesis Pharmaceuticals, South San Francisco, CA.
  • Taverna P; Sunesis Pharmaceuticals, South San Francisco, CA.
  • Combs DL; Combs Consulting Service, Mountain View, CA.
  • Fox JA; Sunesis Pharmaceuticals, South San Francisco, CA.
  • Furman RR; Weill Cornell Medicine, Department of Medicine, New York.
  • Brown JR; CLL Center, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. jennifer_brown@dfci.harvard.edu.
Haematologica ; 107(4): 984-987, 2022 04 01.
Article en En | MEDLINE | ID: mdl-34937320
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article Pais de publicación: Italia